Kiwamoto, T., Kawasaki, N., Paulson, J. C., & Bochner, B. S. (2012). Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
استشهاد بنمط شيكاغوKiwamoto, Takumi, Norihito Kawasaki, James C. Paulson, و Bruce S. Bochner. Siglec-8 As a Drugable Target to Treat Eosinophil and Mast Cell-associated Conditions. 2012.
MLA استشهادKiwamoto, Takumi, Norihito Kawasaki, James C. Paulson, و Bruce S. Bochner. Siglec-8 As a Drugable Target to Treat Eosinophil and Mast Cell-associated Conditions. 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.